| 000 | 01127 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516081754.0 | ||
| 264 | 0 | _c20120703 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1517/13543784.2012.668527 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMerkel, Anna Lena | |
| 245 | 0 | 0 |
_aPIM1 kinase as a target for cancer therapy. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cApr 2012 |
||
| 300 |
_a425-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-pim-1 _xantagonists & inhibitors |
| 700 | 1 | _aMeggers, Eric | |
| 700 | 1 | _aOcker, Matthias | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 21 _gno. 4 _gp. 425-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.2012.668527 _zAvailable from publisher's website |
| 999 |
_c21592329 _d21592329 |
||